The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
The molecular pathogenesis of head and neck squamous cell carcinoma
Open accessAbstract
Clinical and epidemiological featuresSquamous cell carcinoma of the head and neck (HNSCC) is the sixth most common cancer worldwide, affecting 600,000 new patients each year.In the United States, 50,000 new cases are diagnosed, and nearly 10,000 deaths are attributable to this disease annually.Despite their common origin in the squamous mucosa of the upper aerodigestive tract, there are several sources for the heterogeneity of HNSCC that complicate their consideration as a single disease entity.Anatomically, the head and neck region consists of several distinct structures (e.g., lip, tongue, nasopharynx, oropharynx, larynx, hypopharynx) with distinct microscopic features and lymphatic and venous drainage.As a result, treatment approaches and outcomes vary significantly among the different subsites.In addition, etiologic risk factors vary among the different subsites, and HNSCC can occur in young patients without any known risk factors.Biologic heterogeneity independent of subsite has been suggested by molecular analyses that have uncovered distinct classes of HNSCC with unique mRNA expression profiles or patterns of DNA copy number alterations that correlate with clinical behavior (1-4).Although the most important risk factors are tobacco use and alcohol consumption, infection with high-risk types of human papilloma viruses (HPVs) has also been recognized as an increasingly important risk factor, particularly for oropharyngeal squamous cell carcinoma (OPSCC).Importantly, survival for patients with HPV-positive OPSCC is significantly better than for HPV-negative cancers, irrespective of treatment modality (5-8).Possible explanations include both host-intrinsic factors (healthier patients with fewer comorbidities) and tumor-intrinsic factors (distinct genetic pathogenesis yielding enhanced treatment sensitivity).The relatively good prognosis of HPV-related cancers highlights an unfortunate paradox -despite improvements in outcome for patients with oropharynx cancers, little or no improvement has been observed for patients with HPV-negative tumors over the past 30 years (9).This fact is attributable at least in part to our limited understanding of molecular pathways that both promote HSNCC pathogenesis and can be targeted therapeutically.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
Bonner, J. A., Harari, P. M., Giralt, J., Azarnia, N., Shin, D. M., Cohen, R. B., Jones, C. U., Sur, R., Raben, D., Jassem, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053422 · Cited by 5,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling
Engelman, J. A., Zejnullahu, K., Mitsudomi, T., Song, Y., Hyland, C., Park, J. O., Lindeman, N., Gale, C.-M., Zhao, X., Christensen, J., et al. (2007) · Science · doi:10.1126/science.1141478 · Cited by 4,496
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y.-J., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S.-H. I., Dezube, B. J., Jänne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,446
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Barbie, D. A., Tamayo, P., Boehm, J. S., Kim, S. Y., Moody, S. E., Dunn, I. F., Schinzel, A. C., Sandy, P., Meylan, E., Scholl, C., et al. (2009) · Nature · doi:10.1038/nature08460 · Cited by 3,890
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
Chaturvedi, A. K., Engels, E. A., Pfeiffer, R. M., Hernandez, B. Y., Xiao, W., Kim, E., Jiang, B., Goodman, M. T., Sibug-Saber, M., Cozen, W., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.36.4596 · Cited by 3,638
Detection of large-scale variation in the human genome
Iafrate, A. J., Feuk, L., Rivera, M. N., Listewnik, M. L., Donahoe, P. K., Qi, Y., Scherer, S. W., & Lee, C. (2004) · Nature Genetics · doi:10.1038/ng1416 · Cited by 2,892
Fakhry, C., Westra, W. H., Li, S., Cmelak, A., Ridge, J. A., Pinto, H., Forastiere, A., & Gillison, M. L. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn011 · Cited by 2,779
Steck, P. A., Pershouse, M. A., Jasser, S. A., Yung, W. K. A., Lin, H., Ligon, A. H., Langford, L. A., Baumgard, M. L., Hattier, T., Davis, T., et al. (1997) · Nature Genetics · doi:10.1038/ng0497-356 · Cited by 2,741
Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,715
Association of Human Papillomavirus Types 16 and 18 E6 Proteins with p53
Werness, B. A., Levine, A. J., & Howley, P. M. (1990) · Science · doi:10.1126/science.2157286 · Cited by 2,562
The molecular biology of head and neck cancer
Leemans, C. R., Braakhuis, B. J. M., & Brakenhoff, R. H. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2982 · Cited by 2,524
The Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,504
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Engelman, J. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2664 · Cited by 2,445
p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development
Yang, A., Schweitzer, R., Sun, D., Kaghad, M., Walker, N., Bronson, R. T., Tabin, C., Sharpe, A., Caput, D., Crum, C., et al. (1999) · Nature · doi:10.1038/19539 · Cited by 2,225
TP53 mutations in human cancers: origins, consequences, and clinical use.
Olivier, M., Hollstein, M., & Hainaut, P. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a001008 · Cited by 2,199
p63 is a p53 homologue required for limb and epidermal morphogenesis
Mills, A. A., Zheng, B., Wang, X.-J., Vogel, H., Roop, D. R., & Bradley, A. (1999) · Nature · doi:10.1038/19531 · Cited by 1,988
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
Posner, M. R., Hershock, D. M., Blajman, C. R., Mickiewicz, E., Winquist, E., Gorbounova, V., Tjulandin, S., Shin, D. M., Cullen, K., Ervin, T. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070956 · Cited by 1,705
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
Agrawal, N., Frederick, M. J., Pickering, C. R., Bettegowda, C., Chang, K., Li, R. J., Fakhry, C., Xie, T.-X., Zhang, J., Wang, J., et al. (2011) · Science · doi:10.1126/science.1206923 · Cited by 1,697
Ellisen, L. W., Bird, J., West, D. C., Soreng, A. L., Reynolds, T. C., Smith, S. D., & Sklar, J. (1991) · Cell · doi:10.1016/0092-8674(91)90111-b · Cited by 1,696
Self-citationFrequent mutation of histone-modifying genes in non-Hodgkin lymphoma
Morin, R. D., Mendez-Lago, M., Mungall, A. J., Goya, R., Mungall, K. L., Corbett, R. D., Johnson, N. A., Severson, T. M., Chiu, R., Field, M., et al. (2011) · Nature · doi:10.1038/nature10351 · Cited by 1,614
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“As in other human cancers, missense mutations primarily within the DNA binding domain account for 75% of all mutations in the TP53 gene and confer both dominant negative and poorly understood gain-of-function properties (12–15).”
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Pinyol, M., Quesada, V., Conde, L., Ordóñez, G. R., Villamor, N., Escaramis, G., Jares, P., Beà, S., González-Díaz, M., et al. (2011) · Nature · doi:10.1038/nature10113 · Cited by 1,514
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
Cyclin D as a therapeutic target in cancer
Musgrove, E. A., Caldon, C. E., Barraclough, J., Stone, A., & Sutherland, R. L. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3090 · Cited by 1,370
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma
Varela, I., Tarpey, P., Raine, K., Huang, D., Ong, C. K., Stephens, P., Davies, H., Jones, D., Lin, M.-L., Teague, J., et al. (2011) · Nature · doi:10.1038/nature09639 · Cited by 1,123
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069
Notch1 functions as a tumor suppressor in mouse skin
Nicolas, M., Wolfer, A., Raj, K., Kummer, J. A., Mill, P., van Noort, M., Hui, C.-C., Clevers, H., Dotto, G. P., & Radtke, F. (2003) · Nature Genetics · doi:10.1038/ng1099 · Cited by 971
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881
Notch signaling is a direct determinant of keratinocyte growth arrest and entry into differentiation
Rangarajan, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3427 · Cited by 866
Singh, A., Greninger, P., Rhodes, D., Koopman, L., Violette, S., Bardeesy, N., & Settleman, J. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.022 · Cited by 841
TP53 Mutations and Survival in Squamous-Cell Carcinoma of the Head and Neck
Poeta, M. L., Manola, J., Goldwasser, M. A., Forastiere, A., Benoit, N., Califano, J. A., Ridge, J. A., Goodwin, J., Kenady, D., Saunders, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073770 · Cited by 817
Soulieres, D., Senzer, N. N., Vokes, E. E., Hidalgo, M., Agarwala, S. S., & Siu, L. L. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.075 · Cited by 807
Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer
van Haaften, G., Dalgliesh, G. L., Davies, H., Chen, L., Bignell, G., Greenman, C., Edkins, S., Hardy, C., O'Meara, S., Teague, J., et al. (2009) · Nature Genetics · doi:10.1038/ng.349 · Cited by 784
Gastrosplenic Fistula From Hodgkin's Lymphoma
Seib, C. D., Rocha, F. G., Hwang, D. G., & Shoji, B. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7695 · Cited by 735
Pear, W. S., Aster, J. C., Scott, M. L., Hasserjian, R. P., Soffer, B., Sklar, J., & Baltimore, D. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2283 · Cited by 709
High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma.
Reed, A. L., Califano, J. A., Cairns, P., Westra, W. H., Jones, R. M., Koch, W. M., Ahrendt, S. A., Eby, Y. J., Sewell, D. A., Nawroz, H., et al. (1996) · PubMed · Cited by 662
Phase II Trial of ZD1839 in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Cohen, E. E. W., Rosen, F., Stadler, W. M., Recant, W., Stenson, K., Huo, D., & Vokes, E. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.051 · Cited by 610
PRIMA-1 reactivates mutant p53 by covalent binding to the core domain
Lambert, J. M. R., Gorzov, P., Veprintsev, D. B., Söderqvist, M., Segerbäck, D., Bergman, J., Fersht, A. R., Hainaut, P., Wiman, K. G., & Bykov, V. J. N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.003 · Cited by 592
Chung, C. H., Ely, K., McGavran, L., Varella-Garcia, M., Parker, J., Parker, N., Jarrett, C., Carter, J., Murphy, B. A., Netterville, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2587 · Cited by 572
Alterations in components of the TGF-β superfamily signaling pathways in human cancer
LEVY, L., & HILL, C. (2006) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.09.009 · Cited by 539
Scholl, C., Fröhling, S., Dunn, I. F., Schinzel, A. C., Barbie, D. A., Kim, S. Y., Silver, S. J., Tamayo, P., Wadlow, R. C., Ramaswamy, S., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.017 · Cited by 538
Flores, E. R., Sengupta, S., Miller, J. B., Newman, J. J., Bronson, R., Crowley, D., Yang, A., McKeon, F., & Jacks, T. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.019 · Cited by 502
A continuum model for tumour suppression
Berger, A. H., Knudson, A. G., & Pandolfi, P. P. (2011) · Nature · doi:10.1038/nature10275 · Cited by 501
Sok, J. C., Coppelli, F. M., Thomas, S. M., Lango, M. N., Xi, S., Hunt, J. L., Freilino, M. L., Graner, M. W., Wikstrand, C. J., Bigner, D. D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0913 · Cited by 492
p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis
Rocco, J. W., Leong, C.-O., Kuperwasser, N., DeYoung, M. P., & Ellisen, L. W. (2006) · Cancer Cell · doi:10.1016/j.ccr.2005.12.013 · Cited by 433
Self-citationTemam, S., Kawaguchi, H., El-Naggar, A. K., Jelinek, J., Tang, H., Liu, D. D., Lang, W., Issa, J.-P., Lee, J. J., & Mao, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6605 · Cited by 404
Blokzijl, A., Dahlqvist, C., Reissmann, E., Falk, A., Moliner, A., Lendahl, U., & Ibáñez, C. F. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200305112 · Cited by 395
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Klinakis, A., Lobry, C., Abdel-Wahab, O., Oh, P., Haeno, H., Buonamici, S., van De Walle, I., Cathelin, S., Trimarchi, T., Araldi, E., et al. (2011) · Nature · doi:10.1038/nature09999 · Cited by 382
Verdine, G. L., & Walensky, L. D. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2184 · Cited by 361
A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers
Jirawatnotai, S., Hu, Y., Michowski, W., Elias, J. E., Becks, L., Bienvenu, F., Zagozdzon, A., Goswami, T., Wang, Y. E., Clark, A. B., et al. (2011) · Nature · doi:10.1038/nature10155 · Cited by 333
Schache, A. G., Liloglou, T., Risk, J. M., Filia, A., Jones, T. M., Sheard, J., Woolgar, J. A., Helliwell, T. R., Triantafyllou, A., Robinson, M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0388 · Cited by 328
Nickoloff, B. J., Qin, J.-Z., Chaturvedi, V, Denning, M. F., Bonish, B., & Miele, L. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401036 · Cited by 323
Slebos, R. J. C., Yi, Y., Ely, K., Carter, J., Evjen, A., Zhang, X., Shyr, Y., Murphy, B. M., Cmelak, A. J., Burkey, B. B., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2017 · Cited by 311
Fu, M., Rao, M., Bouras, T., Wang, C., Wu, K., Zhang, X., Li, Z., Yao, T.-P., & Pestell, R. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500403200 · Cited by 276
Malecki, M. J., Sanchez-Irizarry, C., Mitchell, J. L., Histen, G., Xu, M. L., Aster, J. C., & Blacklow, S. C. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01655-05 · Cited by 274
Seiwert, T. Y., Jagadeeswaran, R., Faoro, L., Janamanchi, V., Nallasura, V., El Dinali, M., Yala, S., Kanteti, R., Cohen, E. E. W., Lingen, M. W., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2881 · Cited by 269
Smeets, S. J., Braakhuis, B. J. M., Abbas, S., Snijders, P. J. F., Ylstra, B., van de Wiel, M. A., Meijer, G. A., Leemans, C. R., & Brakenhoff, R. H. (2006) · Oncogene · doi:10.1038/sj.onc.1209275 · Cited by 255
Notch tumor suppressor function
Dotto, G. P. (2008) · Oncogene · doi:10.1038/onc.2008.225 · Cited by 244
G�rtner, F., Schmitt, F. C., Preto, A., Reis-Filho, J. S., Simpson, P. T., & Martins, A. (2003) · Virchows Archiv · doi:10.1007/s00428-003-0859-2 · Cited by 235
Saranath, D., Chang, S., Bhoite, L., Panchal, R., Kerr, I., Mehta, A., Johnson, N., & Deo, M. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.133 · Cited by 235
Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue.
Bova, R., Quinn, D. I., Nankervis, J., Cole, I. E., Sheridan, B. F., Jensen, M. R., Morgan, G. J., Hughes, C. J., & Sutherland, R. L. (1999) · PubMed · Cited by 229
Inactivating mutations of caspase-8 gene in colorectal carcinomas
Kim, H. S., Lee, J. W., Soung, Y. H., Park, W. S., Kim, S. Y., Lee, J. H., Park, J. Y., Cho, Y. G., Kim, C. J., Jeong, S. W., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01059-x · Cited by 229
Suppression of Cancer Cell Growth by Promoting Cyclin D1 Degradation
Shan, J., Zhao, W., & Gu, W. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.10.018 · Cited by 229
Licitra, L., Mesia, R., Rivera, F., Remenár, É., Hitt, R., Erfán, J., Rottey, S., Kawecki, A., Zabolotnyy, D., Benasso, M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq588 · Cited by 229
Han, G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24399 · Cited by 224
Bornstein, S., White, R., Malkoski, S., Oka, M., Han, G., Cleaver, T., Reh, D., Andersen, P., Gross, N., Olson, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38854 · Cited by 215
Devgan, V., Mammucari, C., Millar, S. E., Brisken, C., & Dotto, G. P. (2005) · Genes & Development · doi:10.1101/gad.341405 · Cited by 209
Talora, C., Sgroi, D. C., Crum, C. P., & Dotto, G. P. (2002) · Genes & Development · doi:10.1101/gad.988902 · Cited by 206
Lu, S.-L., Herrington, H., Reh, D., Weber, S., Bornstein, S., Wang, D., Li, A. G., Tang, C.-F., Siddiqui, Y., Nord, J., et al. (2006) · Genes & Development · doi:10.1101/gad.1413306 · Cited by 204
PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma
Qiu, W., Schönleben, F., Li, X., Ho, D. J., Close, L. G., Manolidis, S., Bennett, B. P., & Su, G. H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2173 · Cited by 201
Regulation of Notch1 Gene Expression by p53 in Epithelial Cells
Yugawa, T., Handa, K., Narisawa-Saito, M., Ohno, S.-I., Fujita, M., & Kiyono, T. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02119-06 · Cited by 199
Nees, M., Homann, N., Discher, H., Andl, T., Enders, C., Herold‐Mende, C. C., Schuhmann, A., & Bosch, F. X. (1993) · PubMed · Cited by 195
A genetic progression model of oral cancer: current evidence and clinical implications
J. M. Braakhuis, B., René Leemans, C., & H. Brakenhoff, R. (2004) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2004.00225.x · Cited by 190
Crosstalk of Notch with p53 and p63 in cancer growth control
Dotto, G. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2675 · Cited by 188
CASPASE-8 Gene Is Inactivated by Somatic Mutations in Gastric Carcinomas
Soung, Y. H., Lee, J. W., Kim, S. Y., Jang, J., Park, Y. G., Park, W. S., Nam, S. W., Lee, J. Y., Yoo, N. J., & Lee, S. H. (2005) · Cancer Research · doi:10.1158/0008-5472.815.65.3 · Cited by 176
Gain‐of‐function mutations and copy number increases of Notch2 in diffuse large B‐cell lymphoma
Lee, S., Kumano, K., Nakazaki, K., Sanada, M., Matsumoto, A., Yamamoto, G., Nannya, Y., Suzuki, R., Ota, S., Ota, Y., et al. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01130.x · Cited by 174
Sheu, J. J.-C., Hua, C.-H., Wan, L., Lin, Y.-J., Lai, M.-T., Tseng, H.-C., Jinawath, N., Tsai, M.-H., Chang, N.-W., Lin, C.-F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3199 · Cited by 165
Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors.
Okami, K., Wu, L. J., Riggins, G. J., Cairns, P., Goggins, M., Evron, E., Halachmi, N., Ahrendt, S. A., Reed, A. L., Hilgers, W., et al. (1998) · PubMed · Cited by 163
Masica, D. L., & Karchin, R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0180 · Cited by 159
Epidermal growth factor receptor targeted therapy of squamous cell carcinoma of the head and neck
Sharafinski, M. E., Ferris, R. L., Ferrone, S., & Grandis, J. R. (2010) · Head & Neck · doi:10.1002/hed.21365 · Cited by 138
Notch signaling is necessary for epithelial growth arrest by TGF-β
Niimi, H., Pardali, K., Vanlandewijck, M., Heldin, C., & Moustakas, A. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200612129 · Cited by 136
Cohen, E. E. W., Lingen, M. W., Martin, L. E., Harris, P. L., Brannigan, B. W., Haserlat, S. M., Okimoto, R. A., Sgroi, D. C., Dahiya, S. M., Muir, B., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0926 · Cited by 135
Yonesaka, K., Zejnullahu, K., Lindeman, N. I., Homes, A. J., Jackman, D. M., Zhao, F., Rogers, A. M., Johnson, B. E., & Janne, P. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0957 · Cited by 126
NOTCH1-induced T-cell leukemia in transgenic zebrafish
Chen, J., Jette, C. A., Kanki, J. P., Aster, J. C., Look, A. T., & Griffin, J. D. (2007) · Leukemia · doi:10.1038/sj.leu.2404546 · Cited by 115
Wirth, L. J., Haddad, R. I., Lindeman, N. I., Zhao, X., Lee, J. C., Joshi, V. A., Norris, C. M., & Posner, M. R. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.4182 · Cited by 106
Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array
Nakaya, K., Yamagata, H. D., Arita, N., Nakashiro, K., Nose, M., Miki, T., & Hamakawa, H. (2007) · Oncogene · doi:10.1038/sj.onc.1210330 · Cited by 102
Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors
Domínguez, G., Silva, J., Garcia, J. M., Silva, J. M., Rodríguez, R., Muñoz, C., Chacón, I., Sanchez, R., Carballido, J., Colás, A., et al. (2003) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(03)00133-7 · Cited by 98
Gefitinib (ZD1839, Iressa™) as palliative treatment in recurrent or metastatic head and neck cancer
Kirby, A. M., A’Hern, R., D'Ambrosio, C., Tanay, M. A., Syrigos, K. N., Rogers, S. J., Box, C., Eccles, S. A., Nutting, C. M., & Harrington, K. J. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6602999 · Cited by 97
Prognostic Significance of Truncating TP53 Mutations in Head and Neck Squamous Cell Carcinoma
der Plas, M. L.-V., Brakenhoff, R. H., Kuik, D. J., Buijze, M., Bloemena, E., Snijders, P. J. F., Leemans, C. R., & Braakhuis, B. J. M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0183 · Cited by 93
Danilov, A. V., Neupane, D., Nagaraja, A. S., Feofanova, E. V., Humphries, L. A., DiRenzo, J., & Korc, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026815 · Cited by 90
p63 heterozygous mutant mice are not prone to spontaneous or chemically induced tumors
Keyes, W. M., Vogel, H. S., Koster, M. I., Guo, X., Qi, Y., Petherbridge, K. M., Roop, D. R., Bradley, A., & Mills, A. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602477103 · Cited by 88
H-ras Oncogene Mutation and Human Papillomavirus Infection in Oral Carcinomas
Anderson, J. A., Irish, J. C., McLachlin, C. M., et al. (1994) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1994.01880310059011 · Cited by 86
Wang, D., Song, H., Evans, J. A., Lang, J. C., Schuller, D. E., & Weghorst, C. M. (1997) · Carcinogenesis · doi:10.1093/carcin/18.11.2285 · Cited by 85
Smeets, S. J., Brakenhoff, R. H., Ylstra, B., van Wieringen, W. N., van de Wiel, M. A., Leemans, C. R., & Braakhuis, B. J. M. (2009) · Analytical Cellular Pathology · doi:10.1155/2009/267928 · Cited by 81
Rothenberg, S. M., Mohapatra, G., Rivera, M. N., Winokur, D., Greninger, P., Nitta, M., Sadow, P. M., Sooriyakumar, G., Brannigan, B. W., Ulman, M. J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3458 · Cited by 80
Self-citationQiu, W., Schönleben, F., Li, X., & Su, G. H. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.01.003 · Cited by 76
Differential Roles of p16INK4A and p14ARF Genes in Prognosis of Oral Carcinoma
Sailasree, R., Abhilash, A. J. B., Sathyan, K. M., Nalinakumari, K. R., Thomas, S., & Kannan, S. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0284 · Cited by 75
Talora, C., Cialfi, S., Segatto, O., Morrone, S., Choi, J. K., Frati, L., Dotto, G. P., Gulino, A., & Screpanti, I. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.01.015 · Cited by 74
Duan, L., Yao, J., Wu, X., & Fan, M. (2006) · Biology of the Cell · doi:10.1042/bc20060020 · Cited by 73
Rescue of key features of the p63‐null epithelial phenotype by inactivation of Ink4a and Arf
Su, X., Cho, M. S., Gi, Y. J., Ayanga, B. A., Sherr, C. J., & Flores, E. R. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.151 · Cited by 71
Mouse models for human head and neck squamous cell carcinomas
Lu, S., Herrington, H. C., & Wang, X. (2006) · Head & Neck · doi:10.1002/hed.20397 · Cited by 66
Bexarotene and Erlotinib for Aerodigestive Tract Cancer
Dragnev, K. H., Petty, W. J., Shah, S. J., Biddle, A., Desai, N. B., Memoli, V. A., Rigas, J. R., & Dmitrovsky, E. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.9521 · Cited by 63
PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro
Henken, F. E., Banerjee, N. S., Snijders, P. J. F., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-71 · Cited by 61
Pérez‐Sayáns, M., Peñaranda, J. M. S., Díz, P., Barros, F., Gándara-Rey, J. M., & García, A. G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.02.039 · Cited by 50
p63 and p73: Life and Death in Squamous Cell Carcinoma
Rocco, J. W., & Ellisen, L. W. (2006) · Cell Cycle · doi:10.4161/cc.5.9.2716 · Cited by 46
Self-citationNovel mutant‐enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer
Qiu, W., Tong, G., Manolidis, S. L., Close, L. G., Assaad, A. M., & Su, G. H. (2007) · International Journal of Cancer · doi:10.1002/ijc.23217 · Cited by 46
Prevalence of RAS oncogene mutation in head and neck carcinomas.
Ja, A., Jc, I., & By, N. (1992) · PubMed · Cited by 41
Loss of Drop1 expression already at early tumor stages in a wide range of human carcinomas
Marmé, A., Zimmermann, H., Moldenhauer, G., Schorpp‐Kistner, M., Müller, C., Keberlein, O., Giersch, A., Kretschmer, J., Seib, B., Spieß, E., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23763 · Cited by 36
Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance
Millon, R., Müller, D., Schultz, I., Salvi, R., Ghnassia, J., Frébourg, T., Wasylyk, B., & Abecassis, J. (2001) · Oral Oncology · doi:10.1016/s1368-8375(00)00122-6 · Cited by 31
Cited by
Epidemiologic Trends in Head and Neck Cancer and Aids in Diagnosis
Vigneswaran, N., & Williams, M. D. (2014) · Oral and Maxillofacial Surgery Clinics of North America · doi:10.1016/j.coms.2014.01.001 · Cited by 815
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Alsahafi, E., Begg, K., Amelio, I., Raulf, N., Lucarelli, P., Sauter, T., & Tavassoli, M. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1769-9 · Cited by 525
From Fly Wings to Targeted Cancer Therapies: A Centennial for Notch Signaling
Ntziachristos, P., Lim, J. S., Sage, J., & Aifantis, I. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.02.018 · Cited by 374
Britschgi, A., Bill, A., Brinkhaus, H., Rothwell, C., Clay, I., Duss, S., Rebhan, M., Raman, P., Guy, C. T., Wetzel, K., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1217072110 · Cited by 313
Wichmann, G., Rosolowski, M., Krohn, K., Kreuz, M., Boehm, A., Reiche, A., Scharrer, U., Halama, D., Bertolini, J., Bauer, U., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29649 · Cited by 281
Metadata
- Authors
- Rothenberg, S. M., & Ellisen, L. W.
- Venue
- Journal of Clinical Investigation
- Published
- 2012-06-01
- Volume
- 122
- Issue
- 6
- Pages
- 1951-1957
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2096906078
- Cited by
- 363
- References
- 112
- FWCI
- 30.71
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.